“We use cookies on this website to enhance your user experience and to personalise content. By clicking any link or continuing to use our Website you agree to our cookies as per our Privacy Policy. Read More” Ok, I agree

Fluoxetine (Fluoxetine)

Trade Name : Fluoxetine

Teva Pharmaceuticals USA, Inc.

TABLET, FILM COATED

Strength 20 mg/1

FLUOXETINE HYDROCHLORIDE Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]

Delivery Process

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

We’ll Get in Touch

Once we review your request, we’ll send you an estimated price for the medicine within 2-5 days.

Confirmation and Payment

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Product information is meant for

Wholesalers Suppliers Exporters Doctors MOH Tender Supplies Hospitals Brand CROs Comparator Supplies Generic Cooperate Sourcing Individual Patients Indian Institutional Buyers

Disclaimer

Trade Marks displayed in compliance with provisions of: Trademark Act, 1999 u/s 30 and 30 (1) of "Fair use"

GNH India is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India of Fluoxetine (Fluoxetine) which is also known as Fluoxetine and Manufactured by Teva Pharmaceuticals USA, Inc.. It is available in strength of 20 mg/1 per ml. Read more

Fluoxetine (Fluoxetine) is supplied for Tenders/ Emergency imports/ Un - licensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials.  Click to know price.     Read less

Packaging and Delivery

Validated Cold Chain Shipment

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Inquire directly from our website and get 5% off on any medicine!

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Read more

About GNH

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Read more
  • No data
  • When using fluoxetine and olanzapine in combination, also refer to Boxed Warning section of the package insert for Symbyax.
  • WARNING: SUICIDAL THOUGHTS AND BEHAVIORS
  • See full prescribing information for complete boxed warning.
  • When using fluoxetine and olanzapine in combination, also refer to Boxed Warning section of the package insert for Symbyax.
  • Increased risk of suicidal thinking and behavior in children, adolescents, and young adults taking antidepressants (5.1).
  • Monitor for worsening and emergence of suicidal thoughts and behaviors (5.1).
  • Fluoxetine is indicated for the treatment of:
  • When using fluoxetine and olanzapine in combination, also refer to the Clinical Studies section of the package insert for Symbyax.
  • Fluoxetine is a selective serotonin reuptake inhibitor indicated for:
  • Acute and maintenance treatment of Major Depressive Disorder (MDD) ()
  • Acute and maintenance treatment of Obsessive Compulsive Disorder (OCD) ()
  • Acute and maintenance treatment of Bulimia Nervosa ()
  • Acute treatment of Panic Disorder, with or without agoraphobia ()
  • No data
  • A lower or less frequent dosage should be used in patients with hepatic impairment, the elderly, and for patients with concurrent disease or on multiple concomitant medications ()
  • No data
  • Tablets: 10 mg and 20 mg ()
  • When using fluoxetine and olanzapine in combination, also refer to the Contraindications section of the package insert for Symbyax.
  • Serotonin Syndrome and MAOIs: Do not use MAOIs intended to treat psychiatric disorders with fluoxetine or within 5 weeks of stopping treatment with fluoxetine. Do not use fluoxetine within 14 days of stopping an MAOI intended to treat psychiatric disorders. In addition, do not start fluoxetine in a patient who is being treated with linezolid or intravenous methylene blue (4.1)
  • Pimozide: Do not use. Risk of QT prolongation and drug interaction (, , , )
  • Thioridazine: Do not use. Risk of QT interval prolongation and elevated thioridazine plasma levels. Do not use thioridazine within 5 weeks of discontinuing fluoxetine (, , , )
  • When using fluoxetine and olanzapine in combination, also refer to the Contraindications section of the package insert for Symbyax ()
  • When using fluoxetine and olanzapine in combination, also refer to the Warnings and Precautions section of the package insert for Symbyax.
  • Arrayn- Suicidal Thoughts and Behaviors in Children, Adolescents, and Young Adults:
  • Serotonin Syndrome:
  • Allergic Reactions and Rash:
  • Activation of Mania/Hypomania:
  • Seizures:
  • Altered Appetite and Weight:
  • Abnormal Bleeding:
  • Angle-Closure Glaucoma:
  • Hyponatremia:
  • Anxiety and Insomnia:
  • QT Prolongation:
  • Potential for Cognitive and Motor Impairment:
  • Long Half-Life:
  • Fluoxetine and Olanzapine in Combination:
  • The following adverse reactions are discussed in more detail in other sections of the labeling:
  • When using fluoxetine and olanzapine in combination, also refer to the Adverse Reactions section of the package insert for Symbyax.
  • Most common adverse reactions (u2265 5% and at least twice that for placebo) associated with:
  • Major Depressive Disorder, Obsessive Compulsive Disorder, Bulimia, and Panic Disorder: abnormal dreams, abnormal ejaculation, anorexia, anxiety, asthenia, diarrhea, dry mouth, dyspepsia, flu syndrome, impotence, insomnia, libido decreased, nausea, nervousness, pharyngitis, rash, sinusitis, somnolence, sweating, tremor, vasodilatation, and yawn (6.1)
  • Fluoxetine and olanzapine in combination u2013 Also refer to the Adverse Reactions section of the package insert for Symbyax ()
  • To report SUSPECTED ADVERSE REACTIONS, contact u00a0or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
  • As with all drugs, the potential for interaction by a variety of mechanisms (e.g., pharmacodynamic, pharmacokinetic drug inhibition or enhancement, etc.) is a possibility.
  • Monoamine Oxidase Inhibitors (MAOIs):
  • Drugs Metabolized by CYP2D6:
  • Tricyclic Antidepressants (TCAs):
  • CNS Acting Drugs:
  • Benzodiazepines:
  • Antipsychotics:
  • Anticonvulsants:
  • Serotonergic Drugs:
  • Drugs That Interfere With Hemostasis (e.g., NSAIDs, Aspirin, Warfarin):
  • Drugs Tightly Bound to Plasma Proteins:
  • Olanzapine:
  • Drugs That Prolong the QT Interval:
  • When using fluoxetine and olanzapine in combination, also refer to the Use in Specific Populations section of the package insert for Symbyax.
  • Pregnancy:
  • Nursing Mothers:
  • Pediatric Use:
  • Hepatic Impairment:
  • Fluoxetine has not been systematically studied, in animals or humans, for its potential for abuse, tolerance, or physical dependence. While the premarketing clinical experience with fluoxetine did not reveal any tendency for a withdrawal syndrome or any drug seeking behavior, these observations were not systematic and it is not possible to predict on the basis of this limited experience the extent to which a CNS active drug will be misused, diverted, and/or abused once marketed. Consequently, physicians should carefully evaluate patients for history of drug abuse and follow such patients closely, observing them for signs of misuse or abuse of fluoxetine (e.g., development of tolerance, incrementation of dose, drug-seeking behavior).
  • No data
  • Fluoxetine tablets USP are a selective serotonin reuptake inhibitor for oral administration. They are also marketed for the treatment of premenstrual dysphoric disorder (Sarafem, fluoxetine hydrochloride). It is designated (u00b1)--methyl-3-phenyl-3-[(u03b1,u03b1,u03b1-trifluoro--tolyl)oxy]propylamine hydrochloride and has the following structural formula:
  • CHFNOu2022HCl M.W. 345.79
  • Fluoxetine hydrochloride, USP is a white to off-white crystalline solid with a solubility of 14 mg/mL in water.
  • Each tablet contains fluoxetine hydrochloride, USP equivalent to 10 mg (32.3 u03bcmol) or 20 mg (64.7 u03bcmol) of fluoxetine. In addition, each tablet also contains the following inactive ingredients: hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, povidone, pregelatinized corn starch, talc, and titanium dioxide. Additionally, the 10 mg strength contains: D&C Yellow #10 aluminum lake, FD&C Blue #2 aluminum lake, and FD&C Yellow #6 aluminum lake.
  • No data
  • No data
  • Efficacy for fluoxetine was established for the:
  • When using fluoxetine and olanzapine in combination, also refer to the Clinical Studies section of the package insert for Symbyax.
  • No data
  • See the FDA-approved Medication Guide.
  • Patients should be advised of the following issues and asked to alert their prescriber if these occur while taking fluoxetine as monotherapy. When using fluoxetine and olanzapine in combination, also refer to the Patient Counseling Information section of the package insert for Symbyax.
  • FLUOXETINE (floo-OX-e-teen) TABLETS
  • Read the Medication Guide that comes with fluoxetine tablets before you start taking them and each time you get a refill. There may be new information. This Medication Guide does not take the place of talking to your healthcare provider about your medical condition or treatment. Talk with your healthcare provider if there is something you do not understand or want to learn more about.
  • What is the most important information I should know about fluoxetine tablets?
  • Fluoxetine tablets and other antidepressant medicines may cause serious side effects, including:
  • 1. Suicidal thoughts or actions:
  • Keep all follow-up visits with your healthcare provider and call between visits if you are worried about symptoms.
  • Call your healthcare provider right away if you have any of the following symptoms, or call 911 if an emergency, especially if they are new, worse, or worry you:
  • Call your healthcare provider right away if you have any of the following symptoms, or call 911 if an emergency. Fluoxetine may be associated with these serious side effects:
  • 2. Serotonin Syndrome. This condition can be life-threatening and may include:
  • 3. Severe allergic reactions:
  • 4. Abnormal bleeding:
  • 5. Visual problems:
  • 6. Seizures or convulsions
  • 7. Manic episodes:
  • 8. Changes in appetite or weight.
  • 9. Low salt (sodium) levels in the blood.
  • 10. Changes in the electrical activity of your heart (QT prolongation and ventricular arrhythmia including Torsades de Pointes). This condition can be life threatening. The symptoms may include:
  • Do not stop fluoxetine tablets without first talking to your healthcare provider.
  • What are fluoxetine tablets?
  • Fluoxetine tablets are a prescription medicine used to treat depression. It is important to talk with your healthcare provider about the risks of treating depression and also the risks of not treating it. You should discuss all treatment choices with your healthcare provider.
  • Fluoxetine is used to treat:
  • *Not approved for use in children
  • Talk to your healthcare provider if you do not think that your condition is getting better with fluoxetine treatment.
  • Who should not take fluoxetine tablets?
  • Do not take fluoxetine tablets if you:
  • People who take fluoxetine tablets close in time to an MAOI may have serious or even life-threatening side effects. Get medical help right away if you have any of these symptoms:
  • What should I tell my healthcare provider before taking fluoxetine tablets? Ask if you are not sure.
  • Before starting fluoxetine tablets, tell your healthcare provider if you:
  • Tell your healthcare provider about all the medicines that you take,
  • Your healthcare provider or pharmacist can tell you if it is safe to take fluoxetine tablets with your other medicines. Do not start or stop any medicine while taking fluoxetine tablets without talking to your healthcare provider first.
  • If you take fluoxetine tablets, you should not take any other medicines that contain fluoxetine hydrochloride including:
  • How should I take fluoxetine tablets?
  • What should I avoid while taking fluoxetine tablets?
  • Fluoxetine tablets can cause sleepiness or may affect your ability to make decisions, think clearly, or react quickly. You should not drive, operate heavy machinery, or do other dangerous activities until you know how fluoxetine tablets affect you. Do not drink alcohol while using fluoxetine tablets.
  • What are the possible side effects of fluoxetine tablets?
  • Fluoxetine tablets may cause serious side effects, including:
  • Common possible side effects in people who take fluoxetine tablets include:
  • Other side effects in children and adolescents include:
  • Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of fluoxetine tablets. For more information, ask your healthcare provider or pharmacist.
  • CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. YOU MAY REPORT SIDE EFFECTS TO THE FDA AT 1-800-FDA-1088.
  • How should I store fluoxetine tablets?
  • Keep fluoxetine tablets and all medicines out of the reach of children.
  • General information about fluoxetine tablets
  • Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use fluoxetine tablets for a condition for which they were not prescribed. Do not give fluoxetine tablets to other people, even if they have the same condition. They may harm them.
  • This Medication Guide summarizes the most important information about fluoxetine tablets. If you would like more information, talk with your healthcare provider. You may ask your healthcare provider or pharmacist for information about fluoxetine tablets that is written for healthcare professionals.
  • For more information about fluoxetine tablets call 1-888-838-2872.
  • What are the ingredients in fluoxetine tablets?
  • Active ingredient:
  • Inactive ingredients:
  • This Medication Guide has been approved by the U.S. Food and Drug Administration.
  • All brand names listed are the registered trademarks of their respective owners and are not trademarks of Teva Pharmaceuticals USA, Inc.
  • Orap is a registered trademark of Teva Pharmaceuticals USA, Inc.
  • Manufactured In Israel By:
  • Arrayn- Teva Pharmaceutical Ind. Ltd.
  • Jerusalem, 9777402, Israel
  • Manufactured For:
  • Arrayn- Teva Pharmaceuticals USA, Inc.
  • North Wales, PA 19454
  • Rev. M 2/2019
  • NDCn- 7188
  • Fluoxetinen- Tablets USPn- 10 mg
  • PHARMACIST: Dispense theaccompanying Medication Guideto each patient.
  • Rx only
  • 30 TABLETS
  • TEVA
  • NDCn- 0807
  • Fluoxetinen- Tablets USPn- 20 mg
  • PHARMACIST: Dispense theaccompanying Medication Guideto each patient.
  • Rx only
  • 30 TABLETS
  • TEVA

Similar Products

Desogestrel And Ethinyl Estradiol (Emoquette)

Desogestrel And Ethinyl Estradiol (Emoquette)

Manufacturer: REMEDYREPACK INC.

Presentation: KIT

Strength:

Pack Size:

Diphenoxylate Hydrochloride And Atropine Sulfate (Diphenoxylate Hydrochloride And Atropine Sulfate)

Diphenoxylate Hydrochloride And Atropine Sulfate (Diphenoxylate Hydrochloride And Atropine Sulfate)

Manufacturer: REMEDYREPACK INC.

Presentation: TABLET

Strength: 2.5; .025 mg/1; mg/1

Pack Size:

Fluoxetine Hydrochloride (Fluoxetine)

Fluoxetine Hydrochloride (Fluoxetine)

Manufacturer: REMEDYREPACK INC.

Presentation: CAPSULE

Strength: 40 mg/1

Pack Size:

Metoprolol Succinate (Metoprolol Succinate)

Metoprolol Succinate (Metoprolol Succinate)

Manufacturer: REMEDYREPACK INC.

Presentation: TABLET, EXTENDED RELEASE

Strength: 25 mg/1

Pack Size:

Losartan Potassium (Losartan Potassium)

Losartan Potassium (Losartan Potassium)

Manufacturer: REMEDYREPACK INC.

Presentation: TABLET, FILM COATED

Strength: 25 mg/1

Pack Size:

Browse Our Services And Processes

Comparator Sourcing for Clinical Trials

Comparator Sourcing for Clinical Trials

GNH India brings over 10 years of experience in Comparator

Read More

Name Patient Supply

Name Patient Supply

Today, the exact cause for many rare diseases remains unknown

Read More

Validated Cold Chain Shipment

Validated Cold Chain Shipment

With shifting of pharma industry from synthetic molecules to biologic

Read More

Clinical Trials Supply

Clinical Trials Supply

STOP SOURCING..... START SMART SOURCING...... COME STRAIGHT TO THE SOURCE

Read More

Pharmaceutical Contract Manufacturing

Pharmaceutical Contract Manufacturing

GNH Provides Contract Manufacturing services for: Generic Medicines with following

Read More

Pricing

Pricing

PRICING POLICY Terms of sales are typically prepaid, unless otherwise

Read More

Disclaimer

Please see the Legal Notice for detailed terms and disclaimers. The Legal Notice governs the use of this Website and by accessing and using this Website you agree to be bound by and accept the Legal Notice.

Browse from other international pharmaceuticals

General

64020 Products

GNH India Brings to over 64036 Product SKUs from India all at 1 place with easy access and global deliveries.

US NDC

71245 Products

GNH India Brings to over 71252 Product SKUs from India all at 1 place with easy access and global deliveries.

Canadian DIN

51046 Products

GNH India Brings to over 51047 Product SKUs from India all at 1 place with easy access and global deliveries.

Swiss Drugs

150 Products

GNH India Brings to over 150 Product SKUs from India all at 1 place with easy access and global deliveries.

NZ Drugs

13296 Products

GNH Brings to over 13298 Product SKUs from India all at 1 place with easy access and global deliveries.

FAQ

Check out our delivery process

Can’t find what
you’re looking for?

Contact US
Get Price

Are you an existing customer or a vendor of GNH India? Log in here to

View your Transaction
COMPANY
SERVICES
QUICK LINKS
CONTACT US
Registered Office Address:

Unit # G- 14, 15, 16, 17, Ground Floor, Prabhadevi Industrial Estate, Enterprises Industrial Premises, 408, Veer Sawarkar Road, Prabhadevi,
Mumbai 400025 India

US Office Address:

GNH Pharmaceuticals USA LLC,
Suite E # 499, 1235 EAST BLVD,
Charlotte, NC, 28203, U.S.A
TEL: +1 704 557 0412

Pharmexcil
DB
FIEO-2016
SiteLock

Copyright © 2024 GNHIndia .com. All Rights Reserved. Please read Legal Notice for further details.

Disclaimer: Product names, logos, brands and other trademarks featured or referred to are the property of their respective trademark holders.